US stock · figures in US dollars · scored on full-year results
Healthpeak Properties Healthpeak Properties, Inc. Common Stock
Healthpeak Properties scores 47/100 on fundamentals: in the bottom 34% of 503 scored S&P 500 stocks. Its strongest area is Cash & Dividends (100/100); its weakest is Price Fairness (17/100). It carries 1 warning flag: Weak Spot.
- Carries a Weak Spot flag
A financially stretched, expensively priced stock, but price fairness needs attention.
Nearby peers
Ranks #20 of 28 in REIT by score
One-Minute Summary
Why Healthpeak Properties scores 47
A financially stretched, expensively priced stock, but price fairness needs attention.
Business Strength
50Why 50?
Show 3 charts
Net Profit & Equity, with ROE
Revenue & Net Profit, with Net Margin
Sales grew about 35.2% over 4 years: customers keep spending more with this company.
Profit fell about 20.5% from where it was 4 years ago: the boom has cooled off.
Recent Quarters: Revenue & Net Profit (the last 8 quarters, scored)
Sales grew about 10.2% over the last 8 quarters: customers keep spending more with this company.
The company made a loss in at least one of the last 8 quarters: the bars below zero are losses, not profits.
Financial Safety
25Why 25?
Not used for REITs: Current Ratio
Show 2 charts
Debt vs Equity, with D/E ratio
Borrowings grew about 45.7% over 4 years: watch this; rising debt adds pressure in bad times.
Short-term assets vs bills, with Current Ratio
Cash & Dividends
100Why 100?
Show 2 charts
Cash vs Total Debt
Dividends per Share, with Yield
Dividends per share have been maintained or raised: management shares the rewards with you.
Price FairnessLowest pillar
17Why 17?
Show chart
Share Price: Weekly Closes (not part of the score)
The share price is up about 13.3% over the past year.
Risk
20Why 20?
No data: Inventory vs Sales (4yr)
Sector peers
Healthpeak Properties (DOC) scores 47/100 (Okay) on Score Your Stock's educational fundamentals model: in the bottom 34% of 503 scored S&P 500 stocks.
Its strongest pillar is Cash & Dividends (100/100); its weakest is Price Fairness (17/100).
Healthpeak Properties ranks #20 of 28 scored REIT stocks on Score Your Stock.
Yes. Healthpeak Properties (DOC) has a dividend yield of 6.4%, from dividends with an ex-date in the last 12 months. It pays out 348% of its profit as dividends. Its Cash & Dividends pillar scores 100/100.
From Malaysia, open an account with a broker that offers US shares (many local and app-based brokers do), convert ringgit to US dollars, then buy DOC. US shares trade one share at a time, not in lots of 100. Check the currency conversion fee and US dividend tax (usually 30% withheld for Malaysians) before you buy.
The overall score pools every measure across 5 weighted pillars: Business Strength, Financial Safety, Cash & Dividends, Price Fairness, and Risk. It uses the same rules as our Bursa scores. For banks, Financial Safety checks nonaccrual (impaired) loans, loan loss coverage and the CET1 capital ratio, from the FDIC call report of the group's main bank. Full methodology and the default weights: https://scoreyourstock.com/how. This is an educational tool, not investment advice.
Healthpeak Properties (DOC) is a REIT company (REIT - Healthcare Facilities). On Score Your Stock's fundamentals check, it scores 47/100, rated Okay. Its biggest strength is Cash & Dividends (100/100); its main watch-out is Price Fairness (17/100). Shares currently cost about 54 years of its current profit to buy (P/E 53.9×). It also pays back about 6.4% of the share price as dividends each year. Full breakdown and daily-updated score: https://scoreyourstock.com/stocks/us/doc-healthpeak-properties
Full Financial History
Every reported figure behind the score, year by year. Download it, or check it against the company's own annual report.
| Financial Year | Revenue | Net Profit | Operating Cash Flow | Cash | Total Debt | Short-Term Debt | Equity | Current Assets | Current Liabilities | Total Assets | Total Liabilities | Dividends | Return on Equity (ROE) | Net Profit Margin | Debt-to-Equity | Current Ratio | Interest Coverage | Dividend Payout Ratio | Div yield | P/E Ratio | P/B Ratio | PEG Ratio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | US$ 2.9b | US$ 243.3m | US$ 1.2b | US$ 1.6b | US$ 10.3b | US$ 1.5b | US$ 7.8b | US$ 2.1b | US$ 2.2b | US$ 21.7b | US$ 12.2b | - | 3% | 8% | 1.3× | 1.0× | 2.3× | 348% | - | - | - | - |
| 2025 | US$ 2.8b | US$ 71.3m | US$ 1.3b | US$ 467.5m | US$ 10.1b | US$ 1.1b | US$ 7.5b | US$ 1.3b | US$ 1.8b | US$ 20.3b | US$ 12.0b | US$ 122.3m | 1% | 3% | 1.4× | 0.7× | 1.9× | 1190% | 8% | 149.5× | 1.4× | - |
| 2024 | US$ 2.7b | US$ 243.1m | US$ 1.1b | US$ 119.8m | US$ 9.0b | US$ 150.0m | US$ 8.4b | US$ 924.9m | US$ 875.3m | US$ 19.9b | US$ 10.9b | US$ 120.0m | 3% | 9% | 1.1× | 1.1× | 2.0× | 327% | 7% | 52.0× | 1.5× | 1.2 |
| 2023 | US$ 2.2b | US$ 306.0m | US$ 956.2m | US$ 117.6m | US$ 7.1b | US$ 720.0m | US$ 6.4b | US$ 561.3m | US$ 1.4b | US$ 15.7b | US$ 8.8b | US$ 120.0m | 5% | 14% | 1.1× | 0.4× | 2.6× | 215% | 7% | 29.5× | 1.4× | 0.4 |